Brain tumoral epilepsy: A review

Neurological Sciences

Volumn 26, Issue SUPPL. 1, 2005, Pages

  Riva, M ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Anticonvulsants; Brain tumours; Epilepsy; Treatment guidelines

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; METHOTREXATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; STEROID; TOPIRAMATE; VALPROATE SEMISODIUM;

BRAIN METASTASIS; BRAIN TUMOR; CANCER PATIENT; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; GENERAL PRACTITIONER; GLIOMA; HUMAN; HYPERSENSITIVITY; INCIDENCE; LEUKOPENIA; MENINGIOMA; META ANALYSIS; METABOLIC DISORDER; MONOTHERAPY; MORBIDITY; PATHOPHYSIOLOGY; PATIENT CARE; PH; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEIZURE; SIDE EFFECT; SKULL IRRADIATION; STANDARDIZATION; STEVENS JOHNSON SYNDROME; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR RECURRENCE; VENOUS THROMBOEMBOLISM;

ANTICONVULSANTS; BRAIN NEOPLASMS; EPILEPSY; HUMANS;

EID: 18344376565     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0404-y     Document Type: Review

References (15)

1. Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886-1893
2. Hildebrand J (2002) The use of anti-epileptic drugs in neuro-oncology. EANO V - Educational Book. Florence (Italy), pp 179-183
3. Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404-409
4. Moots PL, Maciunas RJ, Eisert DL et al (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717-724
5. Baba M, Karaka M, Alsungur VL et al (2003) The anticonvulsant hypersensitivity syndrome. J Eur Acad Dermatol Venereol 17:399-401
6. French JA, Kanner AM, Bautista J et al (2004) Efficacy and tolerability of the new antiepileptic drugs. II: Treatment of refractory epilepsy. Neurology 62:1261-1273
7. Temkin NR (2002) Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2:105-107
8. Sirven JI, Wingerchuk DM, Drazkowski JF et al (2004) Seizure prophylaxis in patients with brain tumors: A meta-analysis. Mayo Clin Proc 79:1489-1494
9. Schaller B, Stephan JR (2003) Brain tumor and seizures: Pathophysiology and its implications for treatment revisited. Epilepsia 44:1223-1232
10. Beaumont A, Whittle IR (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 142:1-15
11. Riva M, Landonio G, Defanti CA et al (2000) The effect of anticonvulsant drugs on blood levels of methotrexate. J NeuroOncol 48:249-250
12. Riva M (2004) Il trattamento dell'epilessia tumorale: Dall'interferenza con la chemioterapia a uno studio di fase II sull'utilizzo dei "nuovi AEDs". In: Proceedings 'Farmaci antiepilettici e chemioterapici: Quali interazioni farmacologiche', Rome, pp 51-67
13. Riva M, Imbesi F, Collice M et al (2004) Tumour associated epilepsy: clinical pattern in high-grade glioma patients. Neurol Sci 25:94
14. Wiener P (2003) Neuroactive steroids, relaxation, and seizure control. Int J Neurosci 133:613-639
15. Bourg V, Lebrun C, Chichmanian RM et al (2001) Nitrosourea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol 12:217-219